Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

about

Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase.Ebosin: a potential therapeutic agent for rheumatoid arthritis and autoinflammatory syndromes.

P2860

Q39198610-ACCD7BFA-8058-4228-A96A-B157030E0BCE Q50049021-F3E8380A-7698-4B02-8E5C-F511497BE48E

P2860

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

Item

http://www.wikidata.org/entity/Q38907998

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

@en

type

Item

label

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

@en

prefLabel

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

@en

P1476

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

@en

P2093

Celeste B Burness

http://www.w3.org/2001/XMLSchema#string

Sean T Duggan

http://www.w3.org/2001/XMLSchema#string

P2860

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Etanercept biosimilars

A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects.

A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.

A review of CT-P13: an infliximab biosimilar.

Etanercept: a review of its use in autoimmune inflammatory diseases.

Position paper from the Spanish Society of Rheumatology on biosimilar drugs.

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept.

P2888

s40259-016-0188-z

P304

371-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40259-016-0188-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27455991

http://www.w3.org/2001/XMLSchema#string

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

about

P2860

P2860

Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698